Loading
Latest filing published 05 Aug 2026 for Galera Therapeutics, Inc..
No signal scores available.
Michael R. Friedman is a declared insider of Galera Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 7 April 2026 and the latest from 3 August 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 5 August 2026, the filings show a transaction in Galera Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations